Pre-inspected analytical references, active raw compounds, and specialty pharmaceutical intermediates backed by batch-specific HPLC and MS release criteria.
Fladrafinil (CRL-40,941; 2-{[bis(4-fluorophenyl)methyl]sulfinyl}-N-hydroxyacetamide) represents a fluorinated synthetic derivatization of Adrafinil designed for targeted metabolic stability and enhanced central bioavailability.
By substituting para-hydrogen atoms with fluorine moieties on both phenyl rings, Fladrafinil presents altered stereoelectronic characteristics, increasing lipophilicity and blood-brain barrier permeability without increasing cardiovascular adrenergic receptor activation in controlled preclinical assays.
The manufacturing process relies on catalytic alkylation and high-yield nucleophilic aromatic halogenation, requiring rigorous thermal containment to avert regioisomer contamination. Pure crystallites undergo controlled vacuum drying to preserve the labile sulfinyl hydroxamic ester core.
Standard QA protocols demand stringent monitoring of mono-fluorinated analogs and over-oxidized sulfone derivatives (CRL-40,940 related complexes). State-of-the-art multi-stage crystallization ensures assay levels consistently surpass ≥99.2% via RP-HPLC.
| Analytical Parameter | Reference Specification Method | Factory Baseline Standard | Significance in B2B Procurement |
|---|---|---|---|
| Identification (Identity) | 1H-NMR, 13C-NMR & LC-HRMS | Conforms to Structure | Absolute validation of bis-fluorophenyl stereochemistry. |
| Chromatographic Purity (HPLC) | Reverse-Phase C18 (UV at 225nm) | ≥ 99.0% (Single Impurity ≤ 0.5%) | Eliminates synthetic unreacted halides and degradation isomers. |
| Residual Solvents | Headspace Gas Chromatography (GC-MS) | Complies with USP <467> / ICH Q3C | Critical for clean downstream formulation and solvent residue elimination. |
| Heavy Metals Contamination | Inductively Coupled Plasma (ICP-MS) | ≤ 10 ppm Total (Pb, As, Cd, Hg ≤ 1ppm) | Ensures reagent non-toxicity in biomedical and cell culture research. |
| Loss on Drying / Water Content | Karl Fischer Titration | ≤ 0.5% w/w | Guarantees crystalline shelf-stability and accurate stoichiometric dosing. |
Combining upstream chemical raw material integration, continuous batch automation, and comprehensive regulatory documentation to satisfy global enterprise procurement cycles.
Our domestic synthesis lines in Hebei and allied industrial corridors leverage localized raw material sourcing—including bis(4-fluorophenyl)methanol precursors—protecting enterprise clients against global geopolitical shocks and sudden pricing volatility.
From initial gram-scale pilot verification lots to 500-kilogram industrial reactor campaigns, our flexible batch engineering infrastructure allows contract clients to expand commercial trials smoothly without repeating technical validation stages.
Internal solvent recycling infrastructure, process flow optimization, and advanced solvent recovery reduce manufacturing overhead by up to 35% compared to Western contract labs, passing direct savings into multi-ton long-term procurement frameworks.
Mapping clinical investigation, non-clinical behavioral assays, and regional compliance frameworks across major academic, diagnostic, and manufacturing hubs.
Investigated widely within university labs and CROs assessing vigilance pathways, narcolepsy models, and monoamine transporter regulation without peripheral sympathomimetic side-effects typical of conventional amphetamine derivatives.
Employed in preclinical behavioral test batteries (Novel Object Recognition, Morris Water Maze) to map attention span, sleep deprivation rebound indices, and metabolic resilience under simulated sustained-performance stress profiles.
Serves as a critical internal reference standard in analytical toxicology panels, forensic screening, and mass spectrometry profiling libraries identifying novel psychostimulant analogs and designer nootropics.
Transitioning from conventional batch reactors to micro-channel continuous flow platforms to minimize hazardous waste, achieve atom economy, and lock stereospecific chiral purity.
Implementing inline hydrogen peroxide micro-dosing under controlled hydrodynamic conditions to achieve chemo-selective thioether-to-sulfoxide transformation, totally eliminating over-oxidation to sulfone by-products.
Engineering recyclable heterogeneous phase catalysts for carbon-sulfur bond coupling, slashing organic waste (E-Factor) by 45% while elevating batch purity past 99.5% at pilot crystallization.
Advancing stereoselective enzymatic hydrolysis to isolate individual enantiomers (d-Fladrafinil / l-Fladrafinil), enabling institutional partners to conduct comparative receptor-affinity binding studies.
Delivering end-to-end documentary reassurance for legitimate corporate and university research programs worldwide.
Every commercial consignment ships with a complete dossier: Batch Certificate of Analysis (COA), 16-section GHS-compliant Safety Data Sheet (SDS), raw HPLC chromatograms, and NMR spectroscopic plots.
Our customs compliance specialists accurately classify all shipments under international Chapter 29 tariff schedules (Organic Chemicals, Sulfoxides/Amides), preventing delays, audits, or customs disputes at destination borders.
Shipments utilize nitrogen-purged double food-grade polyethylene liners sealed within light-impervious aluminum foil pouches or secure fiber drums, equipped with temperature and moisture desiccants to prevent hydrolytic degradation during sea or air transit.
Direct answers for research directors, lab quality assurance officers, and chemical import procurement specialists.
Fladrafinil incorporates dual para-fluorine atoms on the phenyl rings. This fluorinated modification boosts bio-stability and reduces required research concentrations by inhibiting rapid enzymatic clearance pathways, while maintaining high wakefulness-promoting receptor affinity.
Our crystallization utilizes low-temperature, inert atmosphere precipitation followed by high-vacuum drying below 40°C. This prevents thermal oxidation of the sulfinyl hydroxamic group into secondary sulfones, validated via our HPLC chromatograms accompanying every dispatch.
Yes. In addition to our standard crystalline powder (80-120 mesh), our facility operates enclosed cleanroom jet milling systems capable of supplying micronized particles tailored from D90 < 20 μm up to D50 < 5 μm for demanding formulation assays.
We maintain pilot reference stocks for immediate sampling (100g, 500g, 1kg) ready to dispatch within 24 hours. Bulk enterprise orders (25kg drum increments to metric-ton contracts) follow regular production cycles of 7 to 14 days, supported by air and ocean logistics options.
Comprehensive lyophilized vials, peptide standards, and small-molecule precursors produced under calibrated manufacturing conditions for global laboratory distribution.
